Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Neuroblastoma 2016 NINDS 4U01NS082328-03 Neural Stem Cell Mediated CE-CPT11 Therapy for Neuroblastoma ABOODY, KAREN BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $1,238,896
Neuroblastoma 2016 NCI 5P30CA008748-50 7572 Research Pharmacy MULLER, RAYMOND SLOAN-KETTERING INST CAN RESEARCH NY $206,350
Neuroblastoma 2016 NIGMS 5F32GM109562-03 Genome-wide identification of mRNA localization motifs and factors TALIAFERRO, JEFFERSON MASSACHUSETTS INSTITUTE OF TECHNOLOGY MA $58,002
Neuroblastoma 2016 NINDS 5R21NS092001-02 In Vivo Analysis of TrkB Signaling During Sympathetic Nervous System Development and Neuroblastoma Pathogenesis KULESA, PAUL STOWERS INSTITUTE FOR MEDICAL RESEARCH MO $206,250
Neuroblastoma 2016 NCI 2P30CA014089-41 8290 Tumor Microenvironment Research Program (Project-003) DECLERCK, YVES UNIVERSITY OF SOUTHERN CALIFORNIA CA $35,512
Neuroblastoma 2016 NCI 4P01CA094237-14 7520 VACCINATION TO ENHANCE T CELL IMMUNOTHERAPY HESLOP, HELEN BAYLOR COLLEGE OF MEDICINE TX $295,517
Neuroblastoma 2016 NCI 4P01CA094237-14 7522 ENGINEERING T CELLS FOR PANCREATIC CANCER HESLOP, HELEN BAYLOR COLLEGE OF MEDICINE TX $254,482
Neuroblastoma 2016 NCI 4P01CA094237-14 7530 CHIMERIC T CELLS TARGETING NEUROBLASTOMA HESLOP, HELEN BAYLOR COLLEGE OF MEDICINE TX $295,508
Neuroblastoma 2016 NCI 1K22CA201103-01 Targeting nutrient-sensing pathways in cancer LAZARUS, MICHAEL ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $190,640
Neuroblastoma 2016 NCI 1R21CA187548-01A1 Second generation MIBG analogs that cotarget DNA for high risk neuroblastoma BARANOWSKA-KORTYLEWICZ, JANINA UNIVERSITY OF NEBRASKA MEDICAL CENTER NE $196,403
Neuroblastoma 2016 NCI 5F31CA192558-02 Epigenetic Regulation of Neuroblast Differentiation GAVIGLIO, ANGELA DUKE UNIVERSITY NC $26,208
Neuroblastoma 2016 NCI 1R01CA195732-01A1 The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy LICHT, JONATHAN UNIVERSITY OF FLORIDA FL $343,125
Neuroblastoma 2016 NCI 5P30CA021765-37 6709 Early Phase Clinical Research Support GILBERTSON, RICHARD ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $255,476
Neuroblastoma 2016 NCI 5U10CA180884-03 COG NCTN Solid Malignancy Integrated Translational Science Center ADAMSON, PETER CHILDREN'S HOSP OF PHILADELPHIA PA $400,000
Neuroblastoma 2016 NCI 5R21CA181417-02 Molecular determinants of PARP inhibitor sensitivity in 11q-deleted malignancy FRANCO, SONIA JOHNS HOPKINS UNIVERSITY MD $219,957
Neuroblastoma 2016 NCI 5R01CA180692-02 Role of LMO1 in Neuroblastoma Initiation and Maintenance MARIS, JOHN CHILDREN'S HOSP OF PHILADELPHIA PA $606,838
Neuroblastoma 2016 NCI 4R01CA124709-09 The Genetic Basis of Neuroblastoma Tumorigenesis MARIS, JOHN CHILDREN'S HOSP OF PHILADELPHIA PA $614,290
Neuroblastoma 2016 NCI 1R01CA197903-01A1 Molecular Characteristics of Treatment-resistant High-risk Neuroblastoma ZHONG, JOHN UNIVERSITY OF SOUTHERN CALIFORNIA CA $394,607
Neuroblastoma 2016 NCI 4R01CA166749-04 The Role of Growth Factor Receptor Trafficking in Tumorigenesis ZAGE, PETER BAYLOR COLLEGE OF MEDICINE TX $318,913
Neuroblastoma 2016 NIDA 5R03DA036208-02 Development of Cell-Based Human Dopamine, Norepinephrine, and Serotonin Transporter Release Assays DECKER, ANN RESEARCH TRIANGLE INSTITUTE NC $107,888
Neuroblastoma 2016 NCI 5R01CA172067-05 Optimizing 131I-mIBG Therapy for Children with Advanced Neuroblastoma DUBOIS, STEVEN DANA-FARBER CANCER INST MA $363,426
Neuroblastoma 2016 NCI 5R01CA193890-02 HAUSP inhibitors in p53-wild type and p53-mutant tumors GU, WEI COLUMBIA UNIVERSITY HEALTH SCIENCES NY $366,000
Neuroblastoma 2016 NCI 4R01CA154561-06 Pretherapy 124I-MIBG Dosimetry for Planning 131I-MIBG Neuroblastoma Therapy SEO, YOUNGHO UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $350,001
Neuroblastoma 2016 NCI 4U01CA168426-05 Systems Biology of Tumor Progression and Drug Resistance CALIFANO, ANDREA COLUMBIA UNIVERSITY HEALTH SCIENCES NY $1,238,106
Neuroblastoma 2016 NCI 4U01CA176287-04 Genetic network analysis of cancer targets WEISS, WILLIAM UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $308,486
Neuroblastoma 2016 NCI 5R01CA182633-03 Molecular Diagnostics for Risk Stratification and Monitoring of Neuroblastoma ASGHARZADEH, SHAHAB CHILDREN'S HOSPITAL OF LOS ANGELES CA $665,155
Neuroblastoma 2016 NCI 5R21CA198392-02 A cancer-targeted phospholipid ether analog for molecular radiotherapy of pediatric solid tumors OTTO, MARIO UNIVERSITY OF WISCONSIN-MADISON WI $166,388
Neuroblastoma 2016 NINDS 5R01NS088355-02 Targeting BET-bromodomains in neuroblastoma WEISS, WILLIAM UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $669,055
Neuroblastoma 2016 NCI 5R01CA140198-08 Targeting Oncogenic ALK Signaling in Neuroblastoma MOSSE, YAEL CHILDREN'S HOSP OF PHILADELPHIA PA $374,344
Neuroblastoma 2016 NCI 5R01CA174808-03 Targeting the G-CSF/STAT3 signaling pathway in neuroblastoma cancer stem cells SHOHET, JASON BAYLOR COLLEGE OF MEDICINE TX $326,348
Neuroblastoma 2016 NCI 5R21CA198698-02 Prenatal stress and neuroblastoma development - is there a link? KITLINSKA, JOANNA GEORGETOWN UNIVERSITY DC $169,106
Neuroblastoma 2016 NCI 4R01CA127334-09 Methods for genomic data with graphical structures LEE, HONGZHE UNIVERSITY OF PENNSYLVANIA PA $293,687
Neuroblastoma 2016 NCI 5R01CA057138-25 Employing the Myc Transcriptional Network to Reveal Oncogenic Pathways EISENMAN, ROBERT FRED HUTCHINSON CANCER RESEARCH CENTER WA $635,460
Neuroblastoma 2016 NCI 4R01CA102321-13 Murine Neuroblastoma Models for Preclinical Therapeutics WEISS, WILLIAM UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $261,089
Neuroblastoma 2016 NCI 4R01CA168903-05 Sphingosine-1-Phosphate Pathway Based Therapy for Neuroblastoma SHAPIRO, LINDA UNIVERSITY OF CONNECTICUT SCH OF MED/DNT CT $345,402
Neuroblastoma 2016 NIGMS 4P30GM106396-04 8530 Animal Model Core CHESNEY, JASON UNIVERSITY OF LOUISVILLE KY $241,773
Neuroblastoma 2016 NIGMS 7P20GM103639-05 7853 TARGETED IMMUNOLIPOSOMAL EF24 AGAINST REL ORCHESTRATED NEUR (Natarajan Aravindan) ARAVINDAN, NATARAJAN UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR OK $222,000
Neuroblastoma 2016 NCI 2R01CA116548-11A1 THE INITIATION AND REGULATION OF INFLAMMATION IN NEUROBLASTOMA METELITSA, LEONID BAYLOR COLLEGE OF MEDICINE TX $249,637
Neuroblastoma 2016 NCI 1R01CA197336-01A1 Transcriptional CDKs as therapeutic targets in MYC-dependent cancers GEORGE, RANI DANA-FARBER CANCER INST MA $407,748
Neuroblastoma 2016 NCI 5U01CA199287-02 Pediatric Preclinical Testing Consortium MARIS, JOHN CHILDREN'S HOSP OF PHILADELPHIA PA $357,000
Neuroblastoma 2016 NIDCD 1K23DC014291-01A1 Prevention of Cisplatin-induced Hearing Loss in Children with Cancer ORGEL, ETAN CHILDREN'S HOSPITAL OF LOS ANGELES CA $195,588
Neuroblastoma 2016 NCI 5R01CA197964-02 Neuropeptide Y (NPY) as a hypoxia-driven metastatic factor KITLINSKA, JOANNA GEORGETOWN UNIVERSITY DC $351,644
Neuroblastoma 2016 NCI 1K08CA194162-01A1 The Role of LIN28B Signaling in Mediating the Oncogenic Phenotype in Neuroblastoma SCHNEPP, ROBERT CHILDREN'S HOSP OF PHILADELPHIA PA $73,224
Neuroblastoma 2016 NCI 1K99CA197484-01A1 Identification of novel cooperating partners of MYCN in neuroblastoma tumorigenesis HUANG, MILLER UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $160,773
Neuroblastoma 2016 NCI 5R35CA197078-02 Enhancing Antibody-directed Innate Immunity to Improve Cancer Outcome SONDEL, PAUL UNIVERSITY OF WISCONSIN-MADISON WI $917,625
Neuroblastoma 2016 NCI 4UM1CA097452-15 Pediatric Phase 1/Pilot Consortium WEIGEL, BRENDA CHILDREN'S HOSP OF PHILADELPHIA PA $3,181,202
Neuroblastoma 2016 NCI 5P30CA125123-10 8013 Cancer Cell and Gene Therapy Program (Project-005) HESLOP, HELEN BAYLOR COLLEGE OF MEDICINE TX $43,684
Neuroblastoma 2016 NCI 4K01CA154758-05 MYCN-induced calcium and magnesium signaling regulates Neuroblastoma progression KOOMOA, DANA-LYNN UNIVERSITY OF HAWAII AT HILO HI $134,922
Neuroblastoma 2016 NCI 4P30CA082103-18 6393 Pediatric Malignancies MCCORMICK, FRANK UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $163
Neuroblastoma 2016 NCI 5R00CA178189-04 Pathogenic Roles of SHP2 & PTPRD Tyrosine Phosphatases in High-Risk Neuroblastoma ZHU, SHIZHEN MAYO CLINIC ROCHESTER MN $249,000
Neuroblastoma 2016 NCI 4R01CA168699-04 Pharmacokinetics and pharmacogenomics for 13-cis retinoic acid in neuroblastoma KANG, MIN TEXAS TECH UNIVERSITY HEALTH SCIS CENTER TX $284,060
Neuroblastoma 2016 NCI 2P30CA093373-14 8697 Clinical Protocol and Data Management KELLY, KAREN UNIVERSITY OF CALIFORNIA AT DAVIS CA $282,197
Neuroblastoma 2016 NINDS 5R01NS095411-02 Targeting Tumors with NF1 Loss SANCHEZ, YOLANDA DARTMOUTH COLLEGE NH $547,736
Neuroblastoma 2016 NINDS 1R21NS094654-01A1 TMEM108 IS A NOVEL TARGET IN NEUROBLASTOMA YANG, JIANHUA BAYLOR COLLEGE OF MEDICINE TX $198,125
Neuroblastoma 2016 NCI 1R35CA210030-01 Integrating Transforming Approaches to Identify and Target New Vulnerabilities in Cancer STEGMAIER, KIMBERLY DANA-FARBER CANCER INST MA $1,046,441
Neuroblastoma 2016 NIGMS 1F32GM120956-01 Role of Ubiquitination in Neurocristopathies and Neural Crest-Derived Cancers MARK, KEVIN UNIVERSITY OF CALIFORNIA BERKELEY CA $54,294
Neuroblastoma 2016 NCI 1R01CA204974-01A1 Structural Variation in Neuroblastoma DISKIN, SHARON CHILDREN'S HOSP OF PHILADELPHIA PA $384,300
Neuroblastoma 2016 NCI 5F30CA192831-02 Investigating non-coding mechanisms of functional dysregulation in neuroblastoma OLDRIDGE, DEREK UNIVERSITY OF PENNSYLVANIA PA $30,400
Neuroblastoma 2016 NCI 261200800001E-96-0-142 OCG Data Coordinating Center HEIMBROOK, DAVID LEIDOS BIOMEDICAL RESEARCH, INC. MD $540,000
Neuroblastoma 2016 NIGMS 1R43GM121138-01 Histone phosphorylation-dependent screening platform for identification of inhibitors to treat neuroblastoma SUN, ZU-WEN EPICYPHER, INC. NC $224,326
Neuroblastoma 2016 NCI 2P30CA014089-41 5251 Core-009 GRUBER, STEPHEN UNIVERSITY OF SOUTHERN CALIFORNIA CA $335,322
Neuroblastoma 2016 NCI 1R50CA211437-01 Revealing cancer metabolism via mass spectrometry and isotope tracers LU, WENYUN PRINCETON UNIVERSITY NJ $108,427
Neuroblastoma 2016 NCI 1F99CA212487-01 The role of Lin28/let 7 pathway in Wilms' tumor YERMALOVICH, ALENA HARVARD UNIVERSITY MA $33,026
Neuroblastoma 2016 NCI 3R01CA166749-04S1 The Role of Growth Factor Receptor Trafficking in Tumorigenesis ZAGE, PETER BAYLOR COLLEGE OF MEDICINE TX $13,734
Neuroblastoma 2016 NIDDK 6R01DK061470-13 Surgical Studies on the Role on Gastrin-releasing Peptide in Neuroblastoma CHUNG, DAI VANDERBILT UNIVERSITY MEDICAL CENTER TN $409,278
Neuroblastoma 2016 NCI 7R01CA182526-03 Targeting Neuroblastoma with armed T cells LUM, LAWRENCE UNIVERSITY OF VIRGINIA VA $822,924
Neuroblastoma 2016 NCI 1ZIABC010390-17 Role of Neurotrophins in the Development of the Mammalian Nervous System TESSAROLLO, LINO NIH $743,429
Neuroblastoma 2016 NCI 1ZIABC010701-11 Human Monoclonal Antibodies Against Cancer DIMITROV, DIMITER NIH $909,717
Neuroblastoma 2016 NCI 1ZIABC010788-10 Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma THIELE-GALETTO, CAROL NIH $871,159
Neuroblastoma 2016 NCI 1ZIABC010789-10 Pathophysiologic Consequences of Neurotrophin Activation of Trk in Neuroblastoma THIELE-GALETTO, CAROL NIH $469,085
Neuroblastoma 2016 NCI 1ZIABC010806-10 Developing Novel Therapies for Neuroblastoma and Rhabdomyosarcoma KHAN, JAVED NIH $256,235
Neuroblastoma 2016 NCI 1ZIABC010958-09 Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion DAAR, IRA NIH $685,245
Neuroblastoma 2016 NCI 1ZIABC010998-09 Identification of Novel Mutations In Pediatric Cancers KHAN, JAVED NIH $768,706
Neuroblastoma 2016 NCI 1ZIASC010366-16 Identification of Genes for Predicting Prognosis in Pediatric Cancers KHAN, JAVED NIH $256,235
Neuroblastoma 2016 NCI 1ZICBC011567-03 HiTIF Microscopy Core Facility PEGORARO, GIANLUCA NIH $945,321
Neuroblastoma 2016 NCI 1ZIEBC011516-04 Pediatric Oncology Branch Clinical Care and Education GLOD, JOHN NIH $4,873,680
Neuroblastoma 2016 NCATS 1ZIATR000018-02 Drug Repurposing Screening for Rare and Neglected Diseases ZHENG, WEI NIH $1,292,761


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer